Introduction
Griscelli syndrome (GS) is a rare autosomal recessive disorder resulting in pigmentary dilution of the skin and hair with variable phenotypes dependent upon subtypes. It is also known as hypopigmentation immunodeficiency disease and partial albinism with immunodeficiency. The most prominent features are silvery gray hair and hypopigmentation of skin. Mutations in three different genes-MYO5A, RAB27A, and MLPH are responsible for the 3 subtypes of GS respectively. GS subtype 1 usually manifests with primary dysfunction of the central nervous system without immunological involvement. Subtype 2 is characterized by severe immunological impairment and commonly develops hemophagocytic lymphohistiocytosis (HLH) and recurrent infections while subtype 3 manifests with only partial albinism. Depending on the subtype, the prognosis of GS is variable. There is no specific treatment for GS-1 and prognosis depends on the severity of neurological dysfunction. GS-2 is often fatal as the patients develop accelerated an hemophagocytic syndrome phase secondary to immunological impairment. Therefore, early recognition of patients with GS-2 and prompt intervention with bone marrow transplant is critical. GS-3 does not require treatment. Subtype 2 is the most common and only 13 cases are reported in the literature from India (1-3), which we have summarized in Table  1 and compared with our case in an attempt to highlight the most consistent findings in GS.
Case Report
A 20-month-old boy, third in birth order, born of a non consanguineous marriage, with uneventful antenatal and perinatal history, presented to us with complaints 
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Dr. Richa Choudhary, Department of Pediatrics, SPMCHI, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan 302004, India. E-mail: richa_c8@yahoo.co.in of fever for two months and yellowish discoloration of eyes, body and urine with increasing pallor and weight loss for one month. On Physical examination, his anthropometry parameters were as follows: weight 8.5 kg (below 3rd percentile), length 75 cm (below 3rd percentile), HC 44 cm (below 3rd percentile). On physical examination, child had pallor, icterus, silvery gray hair, white eyelashes, sparse eyebrows and hypopigmented skin (Figure 1 ). On abdominal examination, hepatosplenomegaly was detected. The liver was firm; 5 cm below costal margin with span of 11 cm. Spleen was also firm in consistency and 6 cm enlarged in splenic axis. In laboratory investigation, complete blood counts (CBC) revealed pancytopenia with hemoglobin 2.7 mg/dL, total leukocyte count 2,200/mm 3 USG abdomen showed fatty hepatomegaly, splenomegaly and mild ascites. Bone marrow aspiration and biopsy was suggestive of normoblastic marrow, and hair microscopy showed presence of melanosome clusters along the hair shaft (Figure 2) .
In view of these findings, a diagnosis of GS type 2 was made. For HLH, 5 criteria out of 8 were present (fever, splenomegaly, pancytopenia, raised ferritin and 77 the diagnosis of GS-2 with HLH was made. GS-2, the type reported here, is the most common of all three subtypes. There are only 13 case reports from India of GS-2(1-3), one report of GS-3 (9) with report of no cases of GS-1. Table 1 shows the frequency of clinical and laboratory characteristics of these Indian cases and comparison with our case. The features that were consistently present in all the 13 cases reported, were silvery gray hair, eyelashes, eyebrows; clusters of melanosomes on hair microscopy and hypomelanosis with irregular melanin pigmentation in basal melanocytes on light microscopy of skin. Other frequently occurring features were fever, pallor, hepatosplenomegaly and pancytopenia. Our patient manifested with all the clinical features of GS-2 with HLH although skin biopsy could not be done. Only two previously reported cases (2,10) fulfilled 5 out of 8 criteria to be labeled as HLH, along with documenting hemophagocytosis in bone marrow. In one other case (3), lymphohistiocytosis was demonstrated in an enlarged cervical lymph node, although this case did not meet the criteria of HLH as demonstration of hemophagocytosis alone is neither pathognomonic nor diagnostic for HLH.
Stem cell transplant is the only curative treatment for HLH associated with GS subtype 2 as these children succumb to recurrent infections and secondary neurological involvement (11) . Secondary CNS involvement is caused by the infiltration of lymphocytes and histiocytes as a result of hemophagocytic syndrome.
In conclusion, GS is a rare entity, which shares a close clinical spectrum with Chediak-Higashi syndrome and other immunodeficiencies. Often the greatest barrier to a successful outcome is a delay in diagnosis, which is difficult because of the rarity of this syndrome. High index of suspicion about this condition aids in early recognition and foresees the life threatening complications like HLH. Prompt initiation of treatment with bone marrow transplant is essential for the survival of such affected patients. hypertriglyceridemia/hypofibrinogenemia) but bone marrow aspiration cytology did not reveal findings of HLH.
Supportive therapy including blood transfusion was given to the child and immunosuppresion therapy (mycophenolate mofetil) was started while bone marrow transplantation was advised. Child is currently under follow up and clinical as well as hematological parameters have improved.
Discussion
GS was first described by Griscelli and Siccardi in 1978 (4) . GS usually manifests in persons aged 4 months to 4 years, though the youngest reported is 1 month with no sex predilection (5) .
GS is inherited in an autosomal recessive manner and caused by mutations in one of the three genes. Clinical features of GS depend upon subtype. Hypomelanosis and silvery gray hair are hallmarks of all three GS subtypes. Hypopigmentation of the skin and the hair is accompanied by the presence of large aggregates of pigment in hair shafts and the accumulation of mature melanosomes in melanocytes. GS1 caused by mutations in Myosin-Va gene (MYO5A) presents with neurological involvement without immune dysfunction. GS2 is caused by mutations in the RAB27A gene and is associated with immunological dysfunction without primary neurological impairment. The cytotoxic defect caused by RAB27A mutations is responsible for triggering the hemophagocytic syndrome characterized by acute onset of uncontrolled T-lymphocyte and macrophage activation. Neurological symptoms in GS-2 may be due to infiltration of brain by the activated hematopoietic cells. RAB27A and MYO5A are located at band 15q21 (6, 7) . The third form of GS, being the least common of all, is caused by mutation in the gene MLPH that encodes melanophilin and phenotype of this form is limited to characteristic hypopigmentation without neurologic or immunologic abnormalities. In our case, genetic analysis could not be performed owing to the poor affordability of the parents.
The constellation of symptoms of silvery grey hairs and hepatosplenomegaly raised the possibility of Chediak Higashi and GS as primary diagnosis for this child. Absence of inclusions in granulocytes on peripheral blood examination and hair microscopy findings confirmed the diagnosis of GS and ruled out Chediak Higashi syndrome (8) . Consistent with symptoms described in subtype 2, this child also shared features like fever, pallor, jaundice, hepatosplenomegaly, and fulfilled five criteria of HLH -fever, pancytopenia, splenomegaly, raised ferritin (1,053 ng/mL) and hypertriglyceridemia (triglycerides-311 mg/dL) / hypofibrinogenemia (108 mg/dL). This child did not have any neurological manifestations like seizures, spasticity, or developmental delay, which are usually described in subtype 1. Hence,
